Chung KP - Search Results

1

Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer.

Chen IC, Chang YC, Lu YS, Chung KP, Huang CS, Lu TP, Kuo WH, Wang MY, Kuo KT, Wu PF, Hsueh TH, Shen CY, Lin CH, Cheng AL. Chen IC, et al. Among authors: chung kp. Sci Rep. 2016 Feb 15;6:21374. doi: 10.1038/srep21374. Sci Rep. 2016. PMID: 26877155 Free PMC article.

2

Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment.

Chung KP, Huang YT, Chang YL, Yu CJ, Yang CH, Chang YC, Shih JY, Yang PC. Chung KP, et al. Chest. 2012 Feb;141(2):420-428. doi: 10.1378/chest.10-3149. Epub 2011 Jul 28. Chest. 2012. PMID: 21799026

3

Significant Clinical Factors Associated with Long-term Mortality in Critical Cancer Patients Requiring Prolonged Mechanical Ventilation.

Keng LT, Chung KP, Lin SY, Liang SK, Cheng JC, Chen IC, Chen YF, Chang HT, Hsu CL, Jerng JS, Wang HC, Kuo PH, Wu HD, Shih JY, Yu CJ. Keng LT, et al. Among authors: chung kp. Sci Rep. 2017 May 19;7(1):2148. doi: 10.1038/s41598-017-02418-4. Sci Rep. 2017. PMID: 28526862 Free PMC article.

4

Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR.

Chung KP, Wu SG, Wu JY, Yang JC, Yu CJ, Wei PF, Shih JY, Yang PC. Chung KP, et al. Clin Cancer Res. 2012 Jun 15;18(12):3470-7. doi: 10.1158/1078-0432.CCR-11-2353. Epub 2012 Apr 17. Clin Cancer Res. 2012. PMID: 22510346

5

Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1.

Chung KP, Huang YL, Chen YJ, Juan YH, Hsu CL, Nakahira K, Huang YT, Lin MW, Wu SG, Shih JY, Chang YL, Yu CJ. Chung KP, et al. Mol Oncol. 2021 Feb;15(2):560-578. doi: 10.1002/1878-0261.12843. Epub 2020 Dec 11. Mol Oncol. 2021. PMID: 33152171 Free PMC article.

6

Prognostic significance of dynamin-related protein 1 expression in advanced lung adenocarcinoma.

Huang YL, Chen YJ, Juan YH, Wu SG, Chung KP. Huang YL, et al. Among authors: chung kp. Pathol Res Pract. 2022 Jun;234:153931. doi: 10.1016/j.prp.2022.153931. Epub 2022 Apr 29. Pathol Res Pract. 2022. PMID: 35523103

7

Favorable response to gefitinib treatment of lung adenocarcinoma with coexisting germline and somatic epidermal growth factor receptor mutations.

Chung KP, Shih JY, Yu CJ. Chung KP, et al. J Clin Oncol. 2010 Dec 1;28(34):e701-3. doi: 10.1200/JCO.2010.28.6260. Epub 2010 Sep 7. J Clin Oncol. 2010. PMID: 20823418 No abstract available.

8

High levels of serum macrophage migration inhibitory factor and interleukin 10 are associated with a rapidly fatal outcome in patients with severe sepsis.

Chuang TY, Chang HT, Chung KP, Cheng HS, Liu CY, Liu YC, Huang HH, Chou TC, Chang BL, Lee MR, Lin CJ, Lee SW, Yu CJ, Hsueh PR. Chuang TY, et al. Among authors: chung kp. Int J Infect Dis. 2014 Mar;20:13-7. doi: 10.1016/j.ijid.2013.12.006. Epub 2014 Jan 18. Int J Infect Dis. 2014. PMID: 24445225 Free article.

9

Increased Plasma Acetylcarnitine in Sepsis Is Associated With Multiple Organ Dysfunction and Mortality: A Multicenter Cohort Study.

Chung KP, Chen GY, Chuang TY, Huang YT, Chang HT, Chen YF, Liu WL, Chen YJ, Hsu CL, Huang MT, Kuo CH, Yu CJ. Chung KP, et al. Crit Care Med. 2019 Feb;47(2):210-218. doi: 10.1097/CCM.0000000000003517. Crit Care Med. 2019. PMID: 30379669

10

Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis.

Chung KP, Chen JY, Lee CH, Wu HD, Wang JY, Lee LN, Yu CJ, Yang PC; TAMI Group. Chung KP, et al. Clinics (Sao Paulo). 2011;66(4):549-56. doi: 10.1590/s1807-59322011000400005. Clinics (Sao Paulo). 2011. PMID: 21655745 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page